As U.S. health care systems continue to consolidate, they must be aware of the information technology risks lurking in the shadows. The pace of consolidation remained strong last year, with approximately 1,600 deals. And while megamergers are expected to slow in 2020, larger organizations continue ... READ MORE >
Life sciences
Coronavirus reveals vulnerability in the life science supply chain
As the coronavirus continues to spread and the supply shock to the global economy grows, there is increasing concern about how the outbreak could affect the life sciences industry, especially the availability and quality of drugs and medical equipment. U.S. Food and Drug Administration Commissioner ... READ MORE >
Advances in gene sequencing accelerate the response to coronavirus outbreak
In contrast to China’s slow and secretive acknowledgement of SARS in 2003, the Chinese government and scientific community have been significantly more transparent regarding the coronavirus. On Jan. 31, Health and Human Services Secretary Alex Azar praised China for its “efforts and coordination with ... READ MORE >
Want a fuller picture of biotech’s promise? Look beyond the public markets
A recent Wall Street Journal article highlights the underperformance of the Nasdaq Biotech Index against other benchmarks. The article implies the weak returns are due to a lack of blockbuster biotech therapies; at the same time, the piece underscores the robust private funding activity within the biotech ... READ MORE >
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. The analysis suggests that over 100 biotech companies, including makers of oncology therapies and treatments ... READ MORE >
Better data use has pros and cons for life sciences
The volume and variety of health care data should expand significantly in 2019. Specifically, we will be monitoring growth in data sources outside those collected from traditional electronic health records, including information gleaned from wearable technology and direct-to-consumer genetic testing. Life ... READ MORE >